Objetivo
Allogen Biotech is innovating the ARM-B allergy diagnostics patch technology for use in the healthcare sector and home-test markets. The company’s advanced biosensor concept draws on the simplicity and reliability of traditional skin-prick procedures, yet provides improved clinical outcomes and patient experience. The Allogen innovation is engineered as 50 mm stick-on disc-shaped patch, composed of a microarray device, which identify panels of allergic reactions. Each type of allergic response is interpreted as electrical impedance changes at individual biosensors. The allergy specialist acquires the test results in 5 minutes on a wide panel of common or specific allergens. The sensors register the degree of severity of an allergic reaction and may provide further information on specific testing. The ARM-B system offers unique advantages for the allergy therapist and patients alike. The patch device is non-intrusive – no need to pen-mark or prick large areas of skin: ARM-B microarray extends only 30 mm. The tine-microelectrode structure of the biosensor component ensures ultra-low invasiveness, penetrating only a few hundred microns of epidermis, not millimetre skin-prick depths. Therefore the ARM-B test offers a pain free consultation. The in vivo patch uses only picomole/nL, of a purified allergen microgel, minimising the risk of adverse side effects prevalent with skin-pricks – viz. nausea, raining, malaise. The device offers a large allergy dataset, a consequence of the microarray concept. The sensors are quantitative, so data on degree of allergic response or severity is collated. The solution to skin-oriented allergy diagnostics is applicable to several alternative market segments, not only accredited clinics and general practice with specialist allergy practitioners, but also in the self-test or home-use setting. ARM-B is a high value, low-cost solution for allergy diagnostics.
Ámbito científico
CORDIS clasifica los proyectos con EuroSciVoc, una taxonomía plurilingüe de ámbitos científicos, mediante un proceso semiautomático basado en técnicas de procesamiento del lenguaje natural.
CORDIS clasifica los proyectos con EuroSciVoc, una taxonomía plurilingüe de ámbitos científicos, mediante un proceso semiautomático basado en técnicas de procesamiento del lenguaje natural.
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensorsbiosensors
- medical and health sciencesclinical medicineallergologyfood allergy
- medical and health sciencesclinical medicinepneumologyasthma
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensorssmart sensors
- engineering and technologymedical engineeringmedical laboratory technologylaboratory samples analysis
Programa(s)
Convocatoria de propuestas
Consulte otros proyectos de esta convocatoriaConvocatoria de subcontratación
H2020-SMEInst-2018-2020-1
Régimen de financiación
SME-1 - SME instrument phase 1Coordinador
D03YT25 DUBLIN
Irlanda
Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.